Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Tennessee | Superficial venous ablation · Florida | |
|---|---|---|
| Surgeons, 2024 | 54 | 243 |
| Medicare fee-for-service cases | 5,388 | 23,074 |
| Growth since 2019 (Medicare FFS) | +1.6%/yr | −4.3%/yr |
| Forecast cases (Medicare FFS) | 5,500 in 2030 | 26,100 in 2030 |
| Forecast growth | +0.4%/yr to 2030 | +2.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.3 | 9.8 |
| Medicare Advantage share | 57% | 60% |
| Out of hospital | 100% (+1 pts since 2019) | 100% (+1 pts since 2019) |
| Cases per surgeon | 100 | 95 |
| Top 10 surgeons' share | 58% | 25% |
| Surgeons growing | 15 | 48 |
| New since the base year | 14 | 49 |
| Likely to stop billing it | 6 by 2026 | 40 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $267 | $374 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.